Resultados de la búsqueda 351-360 of 9193 for Drug-resistant TB

1. Mayo Clinic Physician Update - November 2024

   Page 1.

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...

5. Metastatic (stage 4) breast cancer - Diagnósticos y tratamientos - Mayo Clinic

   This test looks for tiny pieces of DNA from cancer cells in the blood. Results can help the healthcare team choose a treatment. Imaging tests. Imaging tests ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

7. Mayo Clinic Physician Update - October 2025

   Page 1.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...